Literature DB >> 15035253

The globalization of clinical trials: a growing challenge in protecting human subjects: executive summary (2001).

.   

Abstract

Entities:  

Keywords:  Biomedical and Behavioral Research; Legal Approach

Mesh：

Substances：

Year:  2003        PMID： 15035253

Source DB:  PubMed          Journal:  J Int Bioethique        ISSN： 1145-0762


× No keyword cloud information.
  11 in total

1.  The invisible hand in clinical research: the study coordinator's critical role in human subjects protection.

Authors:  Arlene M Davis; Sara Chandros Hull; Christine Grady; Benjamin S Wilfond; Gail E Henderson
Journal:  J Law Med Ethics       Date:  2002       Impact factor: 1.718

Review 2.  Vaccine development and trials in low and lower-middle income countries: Key issues, advances and future opportunities.

Authors:  Amy Grenham; Tonya Villafana
Journal:  Hum Vaccin Immunother       Date:  2017-09-02       Impact factor: 3.452

Review 3.  [Globalization in medical research].

Authors:  H-J Ehni; U Wiesing
Journal:  Chirurg       Date:  2018-03       Impact factor: 0.955

4.  Research ethics capacity development in Africa: exploring a model for individual success.

Authors:  Joseph Ali; Adnan A Hyder; Nancy E Kass
Journal:  Dev World Bioeth       Date:  2012-06-18       Impact factor: 2.294

5.  ETHICAL REVIEW OF BIOMEDICAL RESEARCH IN BELARUS: CURRENT STATUS, PROBLEMS AND PERSPECTIVES.

Authors:  Andrei Famenka
Journal:  Rev Rom Bioet       Date:  2011-04

6.  Standardizing clinical trials workflow representation in UML for international site comparison.

Authors:  Elias Cesar Araujo de Carvalho; Madhav Kishore Jayanti; Adelia Portero Batilana; Andreia M O Kozan; Maria J Rodrigues; Jatin Shah; Marco R Loures; Sunita Patil; Philip Payne; Ricardo Pietrobon
Journal:  PLoS One       Date:  2010-11-09       Impact factor: 3.240

7.  Investigator experiences with financial conflicts of interest in clinical trials.

Authors:  Paula A Rochon; Melanie Sekeres; John Hoey; Joel Lexchin; Lorraine E Ferris; David Moher; Wei Wu; Sunila R Kalkar; Marleen Van Laethem; Andrea Gruneir; Jennifer Gold; James Maskalyk; David L Streiner; Nathan Taback; An-Wen Chan
Journal:  Trials       Date:  2011-01-12       Impact factor: 2.279

8.  The case for conducting first-in-human (phase 0 and phase 1) clinical trials in low and middle income countries.

Authors:  Lydia Kapiriri; James V Lavery; Peter A Singer; Hassan Mshinda; Lorne Babiuk; Abdallah S Daar
Journal:  BMC Public Health       Date:  2011-10-18       Impact factor: 3.295

9.  Current globalization of drug interventional clinical trials: characteristics and associated factors, 2011-2013.

Authors:  Sohyun Jeong; Minji Sohn; Jae Hyun Kim; Minoh Ko; Hee-Won Seo; Yun-Kyoung Song; Boyoon Choi; Nayoung Han; Han-Sung Na; Jong Gu Lee; In-Wha Kim; Jung Mi Oh; Euni Lee
Journal:  Trials       Date:  2017-06-21       Impact factor: 2.279

10.  It is time to revise the international Good Clinical Practices guidelines: recommendations from non-commercial North-South collaborative trials.

Authors:  Raffaella Ravinetto; Halidou Tinto; Ermias Diro; Joseph Okebe; Yodi Mahendradhata; Suman Rijal; Eduardo Gotuzzo; Pascal Lutumba; Alain Nahum; Katelijne De Nys; Minne Casteels; Marleen Boelaert
Journal:  BMJ Glob Health       Date:  2016-11-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.